Canagliflozin and Metformin
Brand name: Invokamet
Canagliflozin and Metformin comes in 11 pill versions in our database, in 5 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Canagliflozin and Metformin pill images
50 mg / 500 mg 2 pills
- CM 155 Canagliflozin and Metformin Hydrochloride 50 mg / 500 mg White, oval, 17 mm Used for type 2 diabetes
- CM1 Canagliflozin and Metformin Hydrochloride 50 mg / 500 mg White, oval, 21 mm Used for type 2 diabetes
50 mg / 1000 mg 3 pills
- CM 551 Canagliflozin and Metformin Hydrochloride 50 mg / 1000 mg Brown, oval, 21 mm Used for type 2 diabetes
- CM3 Canagliflozin and Metformin Hydrochloride 50 mg / 1000 mg Pink, oval, 22 mm Used for type 2 diabetes
- No picture yet DIN 02455420 Canagliflozin and Metformin Hydrochloride 50 mg / 1000 mg Invokamet, Tablet, sold in Canada Used for type 2 diabetes
150 mg / 500 mg 2 pills
- CM 215 Canagliflozin and Metformin Hydrochloride 150 mg / 500 mg Yellow, oval, 18 mm Used for type 2 diabetes
- CM2 Canagliflozin and Metformin Hydrochloride 150 mg / 500 mg Orange, oval, 21 mm Used for type 2 diabetes
150 mg / 1000 mg 3 pills
- CM 611 Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg Purple, oval, 22 mm Used for type 2 diabetes
- CM4 Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg Brown, oval, 22 mm Used for type 2 diabetes
- No picture yet DIN 02455455 Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg Invokamet, Tablet, sold in Canada Used for type 2 diabetes
500 mg / 50 mg 1 pill
What is Canagliflozin and Metformin used for?
Canagliflozin and Metformin is used for type 2 diabetes.
- Medicine type
- Diabetes medicine (SGLT2 inhibitor); diabetes medicine (biguanide)
Official uses from the US prescribing label
INVOKAMET
INVOKAMET is a combination of canagliflozin and metformin HCl immediate-release indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
INVOKAMET XR
INVOKAMET XR is a combination of canagliflozin and metformin HCl extended-release indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
Canagliflozin
Canagliflozin, when used as a component of INVOKAMET or INVOKAMET XR, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:
- Major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction and nonfatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD).
- End-stage kidney disease (ESKD), doubling of serum creatinine, cardiovascular (CV) death, and hospitalization for heart failure in adults with type 2 diabetes mellitus and diabetic nephropathy with albuminuria greater than 300 mg/day.
Limitations of Use
INVOKAMET or INVOKAMET XR are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
From the FDA-approved label on DailyMed (published Aug 25, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.